Suprax and Haemoglobin decreased - a phase IV clinical study of FDA data

Summary:

Haemoglobin decreased is reported as a side effect among people who take Suprax (cefixime), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Enzalutamide, and have Urinary tract infection.

The phase IV clinical study analyzes which people have Haemoglobin decreased when taking Suprax. It is created by eHealthMe based on reports of 906 people who have side effects when taking Suprax from the FDA, and is updated regularly.

What is Suprax?

Suprax has active ingredients of cefixime. eHealthMe is studying from 965 Suprax users. Check the latest studies of Suprax.

What is Haemoglobin decreased?

Haemoglobin decreased is found to be associated with 2,405 drugs and 3,133 conditions by eHealthMe. Check the latest studies of Haemoglobin decreased.

On Jul, 30, 2026

906 people reported to have side effects when taking Suprax.
Among them, 12 people (1.32%) have Haemoglobin decreased.

Could Suprax cause Haemoglobin decreased?

Among these 12 people:

How long have people been on Suprax when they have Haemoglobin decreased? *

What is the gender of people who have Haemoglobin decreased when taking Suprax? *

female: 50 %
male: 50 %

What is the age of people who have Haemoglobin decreased when taking Suprax? *

What are other drugs people take besides Suprax? *

What are other side effects people have besides Haemoglobin decreased? *

Haematocrit Decreased: 7 people, 58.33%
Dyspnea (difficult or laboured breathing): 4 people, 33.33%
Blood Creatinine Increased: 4 people, 33.33%
White Blood Cell Count Increased: 3 people, 25.00%
Paleness (unusual lightness of skin colour): 3 people, 25.00%
Red Blood Cell Count Decreased: 3 people, 25.00%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 3 people, 25.00%
Dry Skin: 2 people, 16.67%
Electrocardiogram St Segment Depression: 2 people, 16.67%
Flatulence (flatus expelled through the anus): 2 people, 16.67%

What are the existing conditions these people have? *

Urinary Tract Infection: 2 people, 16.67%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 8.33%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 8.33%
Pneumonia: 1 person, 8.33%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 1 person, 8.33%
Lung Disorder (lung disease): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Gastric Ulcer (stomach ulcer): 1 person, 8.33%
Constipation: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Suprax and have Haemoglobin decreased?

- Check whether Haemoglobin decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Suprax:

Suprax (965 reports)

Browse all side effects of Suprax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemoglobin decreased:

Haemoglobin decreased (2,405 drugs)

Browse all the conditions that are associated with Haemoglobin decreased:

Haemoglobin decreased (3,133 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefixime (the active ingredients of Suprax) and Suprax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.